Viewing StudyNCT00237211



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00237211
Status: COMPLETED
Last Update Posted: 2018-11-14
First Post: 2005-10-09

Brief Title: Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Postmenopausal Women With Advanced Breast Cancer
Keywords:
Name View
breast cancer View
Aromatase inhibitor View
letrozole View